A quadruped robot uses deep reinforcement learning to master walking on varied terrains, demonstrating energy-efficient and ...

FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

Several factors contribute to better battery performance, and in the latest system update, Apple added a background tool based on Apple Intelligence. Jeff Carlson writes about mobile technology for ...

Cardiovascular diseases, including cardiometabolic diseases and related conditions, are the leading causes of death and disability worldwide. 1 Despite advances in pharmacological treatments, ...

Led by Bain Capital Ventures, the investment round brings the total raised by the company to $146.5 million. Adaptive Security has announced raising $81 million in a Series B funding round, the third ...

Dec 15 (Reuters) - Adaptive Biotechnologies (ADPT.O), opens new tab said on Monday it has signed two non-exclusive deals with Pfizer (PFE.N), opens new tab to support research in rheumatoid arthritis ...

Sinéad Burke, chief executive officer of accessibility and inclusion consultancy Tilting the Lens, is pushing forward for adaptive design. Burke has spent the last year working on an open-source white ...

Tinostamustine has received FDA orphan drug designation for malignant gliomas, offering incentives for its development in treating rare conditions. The agent combines bendamustine and vorinostat, ...

Berry Consultants, LLC announced the release of FACTS 8, the latest version of its industry-leading Fixed and Adaptive Clinical Trial Simulator (FACTS). FACTS 8 is ...

Adaptive Biotechnologies has seen significant growth in its MRD segment, now contributing 85% of revenues and achieving segment profitability. Per my estimates, ADPT is priced for ~30% annual revenue ...